Pliant Therapeutics Gets $45M
Redwood City-based Pliant Therapeutics, a new company focused on treatments for fibrotic diseases of the lungs, has raised $45M in a Series A funding. The funding came from Third Rock Ventures. Plaint has named Bernard Coulie, M.D., Ph.D. as its CEO. Coulie was most recently the CEO of ActoGeniX. Third Rock and Pliant said that the company is developing new therapies to treat the pathologic process of fibrotic
disorders.
posted on Thursday, February 18, 2016
Related companies:
Pliant Technology
Related stories:
> Pliant Gains $15M In Series C
> SanDisk Buys Pliant For $327M
> Pliant Gets $8M For SSD Drives
> Pliant Names Engineering VP
> Merck Buys Sirna Therapeutics
silicontap.com Home